Mycobacteria | German Center for Infection Research

Short description

Mycobacteria are a bacterial genus, which includes the -causing Mycobacterium tuberculosis and the leprosy-causing Mycobacterium leprae.

Detailed description

Mycobacteria are commonly found in nature. They exist in soil and water and in all animal species. Some species cause disease in humans.

Mar 2021

Life Sci Alliance

DGCR8 deficiency impairs macrophage growth and unleashes the interferon response to mycobacteria

Autoren

Killy B et al.

Nov 2020

J Immunol

Deficiency of the Intramembrane Protease SPPL2a Alters Antimycobacterial Cytokine Responses of Dendritic Cells

Autoren

Gradtke AC et al.

Nov 2020

Pneumologie

Nontuberculous Mycobacterial Pulmonary Disease: The New ATS/ERS/ESCMID/IDSA Guideline

Autoren

Wagner D

Lange C

Aug 2020

Dtsch Med Wochenschr

[Nontuberculous mycobacterial pulmonary disease - The new ATS/ERS/ESCMID/IDSA Guideline]

Autoren

Wagner D

Lange C

Jul 2020

Clin Infect Dis

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary

Autoren

Daley CL et al.

Jun 2020

Sci Rep

Enhanced tenacity of mycobacterial aerosols from necrotic neutrophils

Autoren

Pfrommer E et al.

May 2020

BMC Infect Dis

Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report

Autoren

Erber J et al.

Tuberculosis: new type of test rapidly and clearly detects resistance

An international team managed by scientists at the Research Center Borstel and the German Center for Infection Research (DZIF) have examined a new method for detecting resistant tuberculosis strains

Jul 2020

Eur Respir J

Treatment of nontuberculous mycobacterial pulmonary disease: An official ATS/ERS/ESCMID/IDSA clinical practice guideline.

Autoren

Daley CL et al.

International recommendations for nontuberculous mycobacteria

After 13 years, international Infectious Diseases and Respiratory Medicine societies have jointly issued new recommendations for the treatment of patients with nontuberculous mycobacteria (NTM). Curre